Love Hormone May Be 'Key' In Coronavirus Treatment

Love Hormone May Be 'Key' In Coronavirus Treatment

...


Scientists from Ohio University in the US think oxytocin, also known as the love hormone, may be playing a 'key role' in the treatment of COVID-19. In the study, details of which were published in the journal Physiological Genomics, the researchers made several important findings.

Scientists think oxytocin, also known as the love hormone, is worth investigating in the treatment of the new type of coronavirus (COVID-19). Ali Imami, a research associate at Ohio University in the U.S., and his colleagues used data from the U.S. National Institutes of health to analyze the characteristics of genes treated with drugs closely linked to oxytocin.

As a result of the investigations, it was observed that a drug called carbetosin, in particular, has similar qualities to genes with a reduced expression of inflammatory markers that trigger a "cytokine storm" in which new types of coronavirus attack the body's own tissues.

Oxytocin has potential in the treatment of cytokine storm in COVID-19 patients:

These properties, also known as the signature of carbetosine, could activate the activity of immune cells called T-cells, which play a key role in immunity to coronavirus, he said. However, carbetosine's signature is also known to resemble lopinavirin, which has been studied as a treatment for COVID-19 and is an antiretroviral therapy.

In a press release from the American Physiological Society, the researchers noted that oxytocin has shown that it may have potential in the treatment of cytokine storm in COVID-19 patients.

Previous research had shown that oxytocin has a role in reducing inflammation, is produced in the brain and is linked to the reproductive and birth process.

In the report, recently published in the journal Physiological Genomics, the authors reported that it is critical to "understand the mechanisms by which oxytocin or the oxytocin system may be a new immune target."



Source